Back to dashboard
All PlansAdministrativeLow impact

[Georgia] Lenalidomide is now available with end‑to‑end REMS support

Anthem BCBS·GA · Oncology, Hematology·Provider Bulletin
Effective date
Not stated
We identified it
May 3, 2026
Days to comply
—

Summary

Lenalidomide (a cancer medication) is now available with end-to-end Risk Evaluation and Mitigation Strategy (REMS) support in Georgia. This provides comprehensive support for the required safety program associated with this high-risk medication.

Action Required

Action needed
Oncology providers and billing teams should be aware that lenalidomide now has enhanced REMS support available. Contact the insurer or REMS program for specific enrollment or utilization procedures if prescribing this medication.

Related policy hubs